{"transactions":[{"id":2080868,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":121450,"kind":"person","name":"Litchev Boyan Vesselinov","position":1,"cik":"0001902726","reported_name":"Litchev Boyan Vesselinov","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-12-20T02:06:32.000Z","date":"2022-12-01","kind":"purchase","acquired":true,"shares":500,"price":1.8709,"value":935.45,"ownership":{"direct":true},"balance_after":1150,"source":{"system":"sec-edgar","filing":"0001493152-22-035926","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315222035926/ownership.xml","form_type":"4"}},{"id":2080867,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":121450,"kind":"person","name":"Litchev Boyan Vesselinov","position":1,"cik":"0001902726","reported_name":"Litchev Boyan Vesselinov","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-12-20T02:06:32.000Z","date":"2022-11-22","kind":"purchase","acquired":true,"shares":500,"price":1.83,"value":915.0,"ownership":{"direct":true},"balance_after":650,"source":{"system":"sec-edgar","filing":"0001493152-22-035926","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315222035926/ownership.xml","form_type":"4"}},{"id":2080866,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":121450,"kind":"person","name":"Litchev Boyan Vesselinov","position":1,"cik":"0001902726","reported_name":"Litchev Boyan Vesselinov","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-12-20T02:06:32.000Z","date":"2022-03-02","kind":"purchase","acquired":true,"shares":50,"price":4.0926,"value":204.63,"ownership":{"direct":true},"balance_after":150,"source":{"system":"sec-edgar","filing":"0001493152-22-035926","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315222035926/ownership.xml","form_type":"4"}},{"id":2080865,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":121450,"kind":"person","name":"Litchev Boyan Vesselinov","position":1,"cik":"0001902726","reported_name":"Litchev Boyan Vesselinov","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-12-20T02:06:32.000Z","date":"2022-01-31","kind":"purchase","acquired":true,"shares":100,"price":4.65,"value":465.0,"ownership":{"direct":true},"balance_after":100,"source":{"system":"sec-edgar","filing":"0001493152-22-035926","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315222035926/ownership.xml","form_type":"4"}},{"id":2415709,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":121450,"kind":"person","name":"Litchev Boyan Vesselinov","position":1,"cik":"0001902726","reported_name":"Litchev Boyan Vesselinov","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-03T00:08:51.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on February 1, 2023 and thereafter the remaining shares vest and become exercisable in equal monthly installments over the following 24 months."}],"balance_after":90000,"derivative":{"exercise_price":4.97,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001493152-22-003030","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315222003030/ownership.xml","form_type":"4"}}]}